We conclude another successful EuroTier, and we want to express our gratitude to everyone who made this important event possible.
Thank you to everyone who visited us. EuroTier always represents a unique opportunity to connect with partners, share ideas, and create new business opportunities.
A special thanks also to our team for their dedication.
See you at EuroTier 2026!
Alivira Spain continues its international expansion with the launch of its phenylpropanolamine-based product in several European countries. Following its successful establishment in Spain and Russia, the company will introduce Uristop®, under the Urixine® brand, to countries such as Portugal, Italy, Germany, Poland, Romania, Austria, Belgium, the Netherlands, and France, among others, totaling 15 countries. The product is expected to receive a similarly positive reception as in its home market.
With a strong presence in the Spanish market, Alivira aims to expand and strengthen its presence in Europe. “After several years of success in Spain, we have identified a growing demand in international markets and believe this is the right time to expand with Urixine,” said Matthieu Gonneaud, Europe Export Manager at Alivira Spain.
About Urixine®
The active ingredient in Urixine®, phenylpropanolamine, is the recommended and most widely used treatment in Spain for urinary incontinence in dogs due to urethral sphincter mechanism incompetence, a common issue in spayed female dogs, particularly those weighing over 20 kg.
With its syrup presentation and dosing syringe, Urixine® offers easy administration and an adaptable and precise dosage, making it ideal for the convenience of both veterinarians and pet owners.
From May 27 to 30, the Alivira group held the second Global Formulation Convention in Antalya, Turkey. More than 40 participants from different countries and continents gathered in Turkey for this annual meeting.
It was 4 days of work meetings, workshops, plenary sessions, and presentations, during which we shared experiences, new projects, and a joint vision to face future challenges in the animal health sector. We take away very good memories of this intense week, interesting learnings, and great motivation to continue working and improving day by day.
Thank you very much to all the participants from the different subsidiaries for your active involvement and great team spirit. We are ALIVIRA!
We are happy & proud to announce that, second time in a row, Alivira has been awarded ‘The best company award from India/ Middle East/ Africa’ for 2020 by Animal Pharm.
Animal Pharm is a leading news and analysis service for the global animal health industry for over 30 years, gathering information on critical developments, emerging trends, changes to the business, regulatory and competitive environment.
Laboratories Karizoo-Alivira has recived the National Sepor Gold Award Entrepreneurship as an innovative company, family origin, dedicated to the veterinary pharmaceutical sector, which aims to improve the health and welfare of the animal production and health and quality life of pets around the world.
Laboratorios Karizoo assisted the “Uniferon Anemia Summit” organiced by Pharmacosmos in Denmark.
Pharmacosmos is a pharmaceutical company, dedicated exclusively to the production and marketing of dextran iron.
In Europe, it is sold whit UNIFERON 200 mg / ml brand, distributed exclusively by Laboratorios Karizoo. UNIFERON is the injectable iron complex who has the lower level of heavy metals on the market, that makes the choice product for the treatment and prevention of iron deficiency anemia in pigs.
In the “Uniferon Anemia Summit”, we had the pleasure to be join by important veterinarians from different places of Spain, and Europe.
